Comments taken from the 41st Annual J.P. Morgan Healthcare Conference.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CVS:
- Oak Street Health, CVS deal would make sense for both companies, says Stifel
- CVS Health sees FY23 MA membership growth in LSD-MSD range
- CVS Health repurchased 15M shares during Q4 at average share price of $99.99
- CVS Health reaffirms FY23 adjusted EPS view $8.70-$8.90, consensus $8.86
- CVS Health reaffirms FY22 adjusted EPS view $8.55-$8.65, consensus $8.63
Questions or Comments about the article? Write to editor@tipranks.com